Search Result |
Top |
| Entry | Name | Description | Category | Pathway | Gene |
|---|---|---|---|---|---|
| H01621 | Pulmonary arterial hypertension | Pulmonary arterial hypertension (PAH) is a progressive disorder in which endothelial dysfunction and vascular remodeling obstruct small pulmonary arteries, resulting in increased pulmonary vascular resistance ... | Cardiovascular disease |
(PPH1) BMPR2 [HSA:659] [KO:K04671] (PPH2) SMAD9 [HSA:4093] [KO:K16791] (PPH3) CAV1 [HSA:857] [KO:K06278] (PPH4) KCNK3 [HSA:3777] [KO:K04914] (PPH5) ATP13A3 [HSA:79572] [KO:K14951] (PPH6) CAPNS1 [HSA:826] [KO:K08583] (HHT2) ACVRL1 [HSA:94] [KO:K13594] (PVOD2) EIF2AK4 [HSA:440275] [KO:K16196] |
|
| H01866 | Pulmonary veno-occlusive disease and pulmonary capillary hemangiomatosis | ... pulmonary oedema can develop with specific PAH therapy. PVOD associated with a BMPR2 mutation has been reported. Recently, it has been suggested that EIF2AK4 mutations are the major cause of heritable PVOD. | Cardiovascular disease |
(PVOD1) BMPR2 [HSA:659] [KO:K04671] (PVOD2) EIF2AK4 [HSA:440275] [KO:K16196] |
| [ KEGG | DISEASE | DRUG | MEDICUS ] |